Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids

This publication has 31 references indexed in Scilit:

• Effects of inhaled corticosteroids on the consequences of asthma
  Journal of Allergy and Clinical Immunology, 1998
• Efficacy of Inhaled Fluticasone Propionate in Asthma Results from Topical and Not from Systemic Activity
  American Journal of Respiratory and Critical Care Medicine, 1997
• Use of inhaled corticosteroids in pediatric asthma
  Pediatric Pulmonology, 1997
• Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study
  Clinical Therapeutics, 1996
• Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma
  Chest, 1995
• Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma
  New England Journal of Medicine, 1994
• Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
  Respiratory Medicine, 1994
• Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler
  Respiratory Medicine, 1993
• Comparison of a β₂-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma
  New England Journal of Medicine, 1991
• The human pharmacology of fluticasone propionate
  Respiratory Medicine, 1990